Lifecore Non-Gynecologic Sales Offset Lost Revenue From Intergel Recall
This article was originally published in The Gray Sheet
Executive Summary
Lifecore Biomedical recorded 6% year-over-year revenue growth for the fiscal third quarter, despite last year's recall of Gynecare Intergel gynecologic surgical adhesion barrier, the company announced April 13